Jim Cramer’s 5 Best Dividend Stocks

2. Merck & Co Inc (NYSE:MRK)

Number of Hedge Fund Investors: 85

Jim Cramer is highly bullish on Merck. In the summer of 2023 Cramer said Merck was doing a “terrific” job at reinventing itself.  In October, Cramer said:

“Yes it is…I think Merck is doing very, very well.”

With over a decade of consistent dividend increases and solid fundamentals, Merck is a highly popular stock among hedge funds.

Carillon Eagle Mid Cap Growth Fund made the following comment about Merck & Co., Inc. (NYSE:MRK) in its Q3 2023 investor letter:

“Merck & Co., Inc. (NYSE:MRK) underperformed in the third quarter, based on what we view as largely macroeconomic-related factors. The company continues to execute well, both clinically and fundamentally, but much of the biopharmaceutical industry has been weak as investors are gravitating to other, more cyclical sectors.”